133 related articles for article (PubMed ID: 1981715)
1. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
Ray GF; Mason WD; Badr MZ
Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
[TBL] [Abstract][Full Text] [Related]
2. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
[TBL] [Abstract][Full Text] [Related]
3. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
4. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
Hoesterey BL; Galinsky RE; Anderson BD
Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination.
Brouwer KR; St Claire RL; Lagarde J; Patanella JE; Walsh JS; Miwa GT
Drug Metab Dispos; 1990; 18(6):1078-83. PubMed ID: 1981516
[TBL] [Abstract][Full Text] [Related]
6. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
7. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
Gallicano KD; Buttar HS; Moffatt JH
Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
9. (-)-6-Aminocarbovir pharmacokinetics and relative carbovir exposure in rats.
Yeager RL; Brouwer KR; Miwa GT
Drug Metab Dispos; 1991; 19(2):462-6. PubMed ID: 1676655
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats.
Epemolu OR; Singh S; Hider RC; Damani LA
Drug Metab Dispos; 1992; 20(5):736-41. PubMed ID: 1358580
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
13. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of carbovir in mice dosed intravenously or orally.
el Dareer SM; Tillery KF; Rose LM; Struck RF; Hill DL
Drug Metab Dispos; 1990; 18(6):842-5. PubMed ID: 1981526
[TBL] [Abstract][Full Text] [Related]
15. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of radiolabelled quinlukast in rats.
Syrovatko M; Laznickova A; Laznicek M
J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
[TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
18. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
[TBL] [Abstract][Full Text] [Related]
19. Disposition of [14C]avitriptan in rats and humans.
Marathe PH; Greene DS; Barbhaiya RH
Drug Metab Dispos; 1997 Jul; 25(7):881-8. PubMed ID: 9224783
[TBL] [Abstract][Full Text] [Related]
20. Disposition of the opioid antagonist, LY255582, in rats and dogs.
Swanson SP; Catlow J; Pohland RC; Chay SH; Johnson T
Drug Metab Dispos; 1995 Sep; 23(9):916-21. PubMed ID: 8565781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
